请输入包含最少两个字元或数字的关键字。
1. Product composition
Standard Kits include:
1. Central Venous Catheter, 2. Clamp, 3. Guide-wire, 4. Vessel Dilator, 5. Fastener: Catheter Clamp , 6. Introducer Syringe, 7. Introducer Needle, 8. Injection Needle, 9. Injection Cap
2. Product characteristics
The Central Venous Catheters can movable clamp allows anchorage at puncture site regardless of depth of catheter, which minimizes trauma and irritation to the puncturing site. Depth marking assists in accurate placement of central venous catheter from the right or left subclavian or jugular vein. Soft tip reduces trauma to vessel, minimizing vessel erosion, hemothorax and cardiac tamponade. Single, double, triple and quad lumen is available for choice.
Radiopacity facilitates confirmation of catheter placement. The multi-lumen version’s tips are more radiopaque, which makes it easy to confirm the placement of fluoroscopic tip. Vessel dilator ensures “super soft” catheters to be easily placed percutaneously.
3. Product catalog
4. Product usage
The Central Venous Catheters may be applicable to the one of following therapy:
- Monitor of central venous pressure;
- Continuous or discontinuous venous transfusion;
- Blood sampling.
The Catheter is surgically penetrated into three optional puncture points depended on the clinical requirement with Seldinger Technique. The Insertion Sites are :
(1). Internal jugular vein;
(2). Subclavian vein;
(3). Femoral vein.
It is possible to be inserted inside the body for no more than 30days. If duration exceeds 30 days, it may occur the risk of combining the catheter and inside tissue, which result in serious incident.
5. Product contraindications
(1). Infection or cut wound around the puncture area.
(2). Dysfunction of blood coagulation.
(3). During the anticoagulant treatment.
(4). Symptoms of inadaptability to puncture operation, such as Pneumothorax, vein sclerosis.
(5). Abnormal or unclear anatomical situation at the penetration area, such as sever emphysema, obviously inadaptability from previous operation.